Evaluating the Cost Effectiveness of Newer Psychotropic MedicationsByGary L. Viale, PharmDFebruary 1st 1997
Looking Beyond the Formulary Budget in Cost-Benefit AnalysisByLawrence J. Cohen, PharmDFebruary 1st 1997
Retrospective Analysis of the Effect of Risperidone on Clinical OutcomeByDaniel C. Javitt, MD, PhD,Arnaldo Negron, MD,Liviu Sigler, MDFebruary 1st 1997
